Peer Review History

Original SubmissionAugust 6, 2024
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Dr Takaine,

Thank you for submitting your manuscript entitled "Condensation of PRPP amidotransferase by phase separation promotes de novo purine synthesis through intermolecular intermediate channeling in yeast" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Aug 22 2024 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Revision 1
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Dr Takaine,

Thanks again for your patience while your manuscript entitled "Condensation of PRPP amidotransferase by phase separation promotes de novo purine synthesis through intermolecular intermediate channeling in yeast" was peer-reviewed at PLOS Biology. The manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by one reviewer. We were expecting to receive an additional report, but the reviewer never sent it. Thus, the Academic Editor has also provided detailed comments on your manuscript.

The review is attached below along with the Academic Editor's comments. As you will see, the reviewer finds your conclusions interesting and worth pursuing for publication, however the reviewer also raises several issues that would need to be addressed. These include analysing how quickly Ade4 condensates disassemble upon Rapamycin treatment, and whether or not this can be prevented with an inhibitor of polysome collapse. This reviewer also thinks you should explore if the PEG concentration correlates with levels of intracellular crowding. The Academic Editor agrees with these points, but has also added a couple of requests that would need to be addressed.

In light of the reviews, which you will find at the end of this email, we would like to invite you to revise the work to thoroughly address the reviewers' reports. Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by the reviewer.

We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type.

3. Resubmission Checklist

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision and fulfil the editorial requests:

a) *PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). Please also indicate in each figure legend where the data can be found. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

b) *Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

c) *Blot and Gel Data Policy*

Please provide the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

d) *Blurb*

Please also provide a blurb which (if accepted) will be included in our weekly and monthly Electronic Table of Contents, sent out to readers of PLOS Biology, and may be used to promote your article in social media. The blurb should be about 30-40 words long and is subject to editorial changes. It should, without exaggeration, entice people to read your manuscript. It should not be redundant with the title and should not contain acronyms or abbreviations. For examples, view our author guidelines: https://journals.plos.org/plosbiology/s/revising-your-manuscript#loc-blurb

e) *Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

------------------------------------

Reviewers' comments

Rev. 1:

In this interesting study, Takaine et al investigate how the S. cerevisiae PRPP amidotransferase Ade4 is regulated in different nutrient conditions. They describe that Ade4 forms highly dynamic and reversible foci upon purine starvation. Formation of these foci can be prevented by deletion of a conserved IDR region in the protein or by addition of hexane diol, leading the authors to conclude that the observed foci represent liquid condensates. These condensates seem to depend on high levels of intracellular crowding as Ade4 focus formation depends on TORC1 induced ribosome biogenesis and synthetic crowding agents (PEG, Ficoll) induce purified Ade4 to undergo a phase transition in vitro. Furthermore, the authors describe how metabolic changes that occur in response to purine starvation promote Ade4 condensation. In vitro, Ade4 condensation is strongly increased by binding to its substrate PRPP and slightly inhibited by AMP. At high crowding levels the positive effect of PRPP is however only modest. To assess the functional relevance of the identified metabolite- and crowding dependent condensation of Ade4, the authors performed molecular dynamics simulations that suggest that condensation supports substrate channeling between the active sites of Ade4. I am not qualified to assess the quality of these molecular dynamics calculations. Finally, the authors show that deletion of the IDR domain in Ade4 reduces cell fitness in purine depleted conditions.

Overall, this is an exciting manuscript with an impressive amount data. The experimental data are of high quality and generally support the author's conclusions. I have a number of points the authors might want to address before publication

1. From the observation that Ade4 focus formation depends on TORC1 and Sfp1 activity, the authors conclude that ribosome biogenesis dependent crowding is needed for condensate formation. A recent study by the Holt lab (PMID: 39059370 ) suggests that polysomes rather than individual ribosomes play a major role in cytoplasmic crowding. As polysomes collapse much faster than overall ribosome concentration decreases, it would be interesting to see how quickly Ade4 condensates disassemble upon Rapamycin treatment and whether it can be prevented by simultaneous treatment with Cycloheximide (prevents polysome collapse).

2. While PRPP can boost condensate formation at intermediate PEG concentrations, at high concentrations (10%) PRPP is much less potent at inducing Ade4 condensation. Whether or not PRPP levels are important in regulating Ade4 condensates therefore depends on the level of crowding in the cytoplasm. It would be useful if the authors could relate the PEG concentration to levels of intracellular crowding.

3. It would help if the negative control for the in vitro condensation experiments (mNG, Figure S4B) would be shown next to the Ade4-mNG condensates in the main figure and displayed in the same way (inverted intensities).

4. The authors show that ADE4-IDR∆ mutants display a growth defect on ADE- which is accentuated in the absence of ammonium. This is consistent with the idea that Ade4 condensation promotes purine synthesis by substrate channeling. Another possible interpretation of these data is that deleting the IDR domain reduces the intrinsic enzymatic activity of Ade4 and that the observed growth defect on Ade- is caused by this mutation. Do the authors have data to exclude this possibility. If not, they should at least discuss this possibility.

Comments from the Academic Editor

I share reviewer 1’s enthusiasm for this manuscript and would like to see the authors address their comments. I additionally have a couple of requests:

i/ Line 245: …However, environmental purine bases, including adenine, do not affect TORC1 activity in mammalian cells 29, 30. I don’t think these references come to this conclusion. I would recommend determining if TORC1 activity is affected by the treatments performed in figure 5B. This may be particularly important given that phosphorylation of Prs5 is potentially regulated downstream of TORC1 (DOI: 10.1101/gad.532109).

ii/ The molecular dynamics data are quite compelling, but I would like to see these hypotheses confirmed in vivo if possible. For example, does the Arg333Ala mutant have any phenotypes in yeast? Could it perhaps rescue the slow growth phenotype when introduced into the Ade4ΔIDR-3HA gene?

Revision 2

Attachments
Attachment
Submitted filename: Response_v5.pdf
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Dr Takaine,

Thank you for the submission of your revised Research Article entitled "Phase separation of the PRPP amidotransferase into dynamic condensates promotes de novo purine synthesis in yeast" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Robbie Loewith, I am delighted to let you know that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Many congratulations and thanks again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely, 

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .